Year: 2012
Type: article
Abstract: In 2004, Klastersky et al. reported that fever is a common finding in patients with hematologic malignancies, occurring in more than 80% of the patients during or after chemotherapy.[1] He and his colleagues also reported that the most feared infection in neutropenic patients is bloodstream infection (BSI), which significantly increases the mortality rate of these patients.[2] In 2009, Viscoli et al. [3] and 10 years later Bodey [4] came into the same conclusion that the identification of the BSI by clinical means is complicated due to the fact that in neutropenic patients, the common signs of infection are usually absent and the only clinical sign of BSI is fever.The aim of this study is to determine the frequency and type of infections that cause fever in neutropenic patients and how many of these febrile episodes may be due to BSI.This cross-sectional study was conducted in Sayed Al-Shohada Hospital, Isfahan, Iran.All febrile neutropenic patients who were admitted in Sayed Al-Shohada Hospital during the period 2005-2010 were included (by assessing their medical documents).The data were analyzed using χ 2 -test, independent sample t-test, or variance analysis.Out of 375 patients in this study, 77.3% and 22.7% of them were classified as Fever of Unknown Origin (FUO) and sepsis, respectively.In 68.4% of
Source: PubMed Central
Authors: Mohsen Meidani, Mojtaba Rostami, Sareh Moulaee
Institution: Isfahan University of Medical Sciences
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W1946092589
